News

NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 – Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application

SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the…

2 years ago

Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May

ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter…

2 years ago

H1 and Lightship Partner to Accelerate Clinical Studies with Diversity, Equity, and Inclusion Data

Leveraging H1’s Trial Landscape solution, Lightship will incorporate important diversity data into its clinical trials process, bringing life-changing therapies to…

2 years ago

Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics

New strains to provide crucial insights in mental health research across the sector Optimi Health Functional Mushrooms Optimi Health Lion's…

2 years ago

Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)

FDA granted IND clearance for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic…

2 years ago

Icario/Harris Poll Survey Uncovers Challenges Associated with Educating Medicaid Members on Redetermination and Re-enrollment

Findings Reaffirm Significant Disparities Between Higher-and Lower-Income Members, While Only 56% of Members Report Receiving Helpful Info About Medicaid Redetermination…

2 years ago

Virax Biolabs Introduces New Board of Directors, Announces Members

London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United…

2 years ago

New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy

Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE)…

2 years ago

Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022

MIAMI, May 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for…

2 years ago

Trusting Heart Blood Center’s Documentary, “The Platelet Problem,” is Recognized in the Top Ten at the 26th Annual Webby Awards

Webby Award Trusting Heart Blood Center’s Webby Award for their microdocumentary, ‘The Platelet Problem,’ placing in the top 10 Best…

2 years ago